MedPath

Gentamicin intratympanic injection concurrent with dexamethasone in refractory Meniere’s disease.

Not Applicable
Recruiting
Conditions
Diseases of the ear and mastoid process
Registration Number
KCT0008375
Lead Sponsor
Yonsei University Health System, Severance Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Definite Meniere’s disease
-If there is no improvement in medication treatment for more than 3 months and there is more than 1 dizziness attack per month
-The average hearing on the affected side is more than mild hearing loss (0.5, 1, 2, 3 kHz average airway hearing threshold > 25 dB on pure tone audiometry)

Exclusion Criteria

-When CNS-caused dizziness is suspected
-Symptoms after head trauma
-Past history of other otological diseases such as otitis media
-Bilateral Meniere's disease
-Taking steroids for an underlying disease
-If the affected side is the better ear (when the average airway hearing threshold of the affected side is lower than the contralateral side on pure tone audiometry)

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hearing difference between the two groups after treatment
Secondary Outcome Measures
NameTimeMethod
Proportion of patients who dropped out due to the need for additional treatment after treatment in both groups;Serial hearing change after treatment in both groups;Changes in vestibular function (caloric, vHIT) after treatment in both groups;Frequency of dizziness after treatment in both groups
© Copyright 2025. All Rights Reserved by MedPath